HF
IONS icon

HRT Financial’s Ionis Pharmaceuticals IONS Stock Holding History

HRT Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Buy
+30,000
New +$2.26M ﹤0.01% 1635

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HRT Financial's IONS Position: Q2 2026 in Review

HRT Financial reduced its Ionis Pharmaceuticals (IONS) stake by 38% in Q2 2026, selling an estimated $7.18M and leaving 156,798 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #679.

HRT Financial first reported a position in IONS in Q3 2019 and has held it in 14 quarters since. The position peaked at $18.9M in Q1 2026. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • HRT Financial held 156,798 shares of Ionis Pharmaceuticals worth $12.4M as of Q2 2026.
  • HRT Financial sold 95,452 Ionis Pharmaceuticals shares in Q2 2026, an estimated $7.18M.
  • Ionis Pharmaceuticals made up 0.02% of HRT Financial's portfolio in Q2 2026, its #679 holding.
  • HRT Financial first reported a position in Ionis Pharmaceuticals in Q3 2019 and has held it in 14 quarters since.
  • HRT Financial's Ionis Pharmaceuticals position peaked at $18.9M in Q1 2026.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.